There are mixed opinions on the stock, with 5 analysts rating it as a “buy,” 1 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for CYBN is 18.31M and currently, short sellers hold a 2.14% ratio of that float. The average trading volume of CYBN on September 25, 2024 was 163.96K shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
CYBN) stock’s latest price update
The stock price of Cybin Inc (AMEX: CYBN) has jumped by 4.65 compared to previous close of 10.00. Despite this, the company has seen a gain of 35.00% in its stock price over the last five trading days. businesswire.com reported 2024-09-24 that TORONTO–(BUSINESS WIRE)–Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options, is pleased to announce that Amir Inamdar, Cybin’s Chief Medical Officer, will participate in a panel discussion at the TD Cowen 4th Annual Novel Mechanisms in Neuropsychiatry Summit taking place virtually on September 26, 2024. T.
CYBN’s Market Performance
CYBN’s stock has risen by 35.00% in the past week, with a monthly rise of 3.30% and a quarterly rise of 4.24%. The volatility ratio for the week is 14.52% while the volatility levels for the last 30 days are 10.38% for Cybin Inc The simple moving average for the past 20 days is 20.89% for CYBN’s stock, with a -17.82% simple moving average for the past 200 days.
CYBN Trading at 7.13% from the 50-Day Moving Average
After a stumble in the market that brought CYBN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -62.68% of loss for the given period.
Volatility was left at 10.38%, however, over the last 30 days, the volatility rate increased by 14.52%, as shares surge +2.89% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -13.12% lower at present.
During the last 5 trading sessions, CYBN rose by +34.16%, which changed the moving average for the period of 200-days by -34.05% in comparison to the 20-day moving average, which settled at $8.67. In addition, Cybin Inc saw -32.83% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for CYBN
The total capital return value is set at -0.33. Equity return is now at value -49.29, with -47.66 for asset returns.
Based on Cybin Inc (CYBN), the company’s capital structure generated 0.0 points at debt to capital in total, while cash flow to debt ratio is standing at -402.95.
Currently, EBITDA for the company is -78.41 million with net debt to EBITDA at 2.0. The liquidity ratio also appears to be rather interesting for investors as it stands at 41.70.
Conclusion
In conclusion, Cybin Inc (CYBN) has seen mixed performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
